4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-027354
CHIEF OPERATING OFFICER sold 17,000 shares at $21.04 ($357,680)
- CHIEF OPERATING OFFICER acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2024-11-18 | Option exercise 10b5-1 | +10,000 | $1.59 | $15,900 | 119,975 | D: show line 1 in the form |
| Tessari Eben CHIEF OPERATING OFFICER | 2024-11-18 | Sale 10b5-1 | −17,000 | $21.04 | $357,680 | 102,975 | D: show line 2 in the form |
| Open-market sales · 17,000 sh · avg $21.04 · $357,680 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2024-11-18 | Option exercise · Share Option 10b5-1 | −10,000 | 16,017 | D: show line 3 in the form |
Loading xslF345X05/form4-11202024_091114.xml…